A route to optically active variously substituted 4‐methyl‐ and 4‐methyl‐7‐substituted 1,3,4,5‐tetrahydro‐2 H ‐1,5‐benzo‐diazepin‐2‐ones as analogues of commercially available Lofendazam (7‐chloro‐5‐phenyl‐1,3,4,5‐tetrahydro‐2 H ‐1,5‐benzodiazepin‐2‐one, 1 ) was developed. Fortyone variously substituted optically active compounds having the same configuration were prepared and the UV and CD spectra of the parent compounds bearing no additional substitution in the benzene ring are discussed.
No takes yet. Share an insight, caveat, or question.
Malik et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: